Rel-O-2050
Rel-O-2050 (Compound O-2050) is a neutral cannabinoid CB1 receptor antagonist. rel-O-2050 also decreases food intake in mice[1].
Product Specifications
CAS Number
[851320-29-1]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rel-o-2050.html
Solubility
10 mM in DMSO
Smiles
CS(=O)(NCCCC#CCC1=CC(O)=C([C@@]2([H])[C@](CC=C(C)C2)([H])C(C)(C)O3)C3=C1)=O
Molecular Formula
C23H31NO4S
Molecular Weight
417.56
References & Citations
[1]Wiley JL, et al. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB (1) receptor antagonist. Eur J Pharmacol. 2011 Jan 25;651 (1-3) :96-105.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
132591-Biotin 100 µL
RING1 (E3 Ubiquitin-protein Ligase RING1, RING Finger Protein 1, Polycomb Complex Protein RING1, Really Interesting New Gene 1 Protein, RNF1) (Biotin)
Ask
View Details